https://doi.org/10.1002/humu.23818
H
Hongyan Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
389
Citations
8
h-index
7
i10-index
Hongyan Li is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Melanoma and MAPK Pathways & Protein Tyrosine Phosphatases & Cancer-related Molecular Pathways. The author has an h-index of 8, co-authored 18 publications.
ORCID: 0009-0008-8094-9289Papers by this author
worksLarge scale multifactorial likelihood quantitative analysis of <i>BRCA1</i> and <i>BRCA2</i> variants: An ENIGMA resource to support clinical variant classification
2019 · Human Mutation · 150 citations
Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
2019 · Genetics in Medicine · 39 citations
https://doi.org/10.1038/s41436-019-0729-1
Dysfunction of PDE4DIP contributes to LVNC development by regulating cell polarity, skeleton, and energy metabolism via Rho-ROCK pathway
2025 · Genes & Diseases · 1 citations
https://doi.org/10.1016/j.gendis.2025.101568
Supplementary Video-2 from Tumorigenesis Driven by BRAF<sup>V600E</sup> Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration
2025 · 0 citations
https://doi.org/10.1158/0008-5472.28917809
Increased Long Noncoding RNA HCG18 Indicates the Adverse Prognosis and Deteriorating Development of Diffuse Large B Cell Lymphoma Through Suppressing miR‐494‐3p
2025 · European Journal of Cancer Care · 0 citations
https://doi.org/10.1155/ecc/8839021
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat